Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Instruments Plc LSE:OXIG London Ordinary Share GB0006650450 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -10.00 -0.65% 1,540.00 1,544.00 1,548.00 1,564.00 1,536.00 1,564.00 56,712 16:35:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 333.6 35.5 52.4 29.4 886

Oxford Instruments Share Discussion Threads

Showing 626 to 648 of 800 messages
Chat Pages: 32  31  30  29  28  27  26  25  24  23  22  21  Older
DateSubjectAuthorDiscuss
29/9/2015
15:20
Dare I say it but the price has begun to stabilise around £6 now. I suspect a long slow haul upwards will ensue , barring more bad news.
wad collector
18/9/2015
16:30
In my experience they stay on the gravy train till they get booted off. There is nearly always a back story-the RNS releases are designed to smooth over any issues.But some may do as you suggest and leave voluntarily.
meijiman
18/9/2015
16:00
Such cynicism. There must often be an element of CEOs departing because they know bad news is coming and don't want it to be their swansong.
wad collector
18/9/2015
07:53
If that's right than I stand corrected because that's not long enough to make a difference. It is rather remiss of me not be on top of the detail but I had rather put this into the box to forget about. No one should be judged much before 18 months really. As an aside its simply staggering how many companies undergo profit warnings/kitchen sink provisioning after a new ceo is installed. Wonder if its linked to options!
meijiman
17/9/2015
20:50
I suppose that it could be argued that he has only been in post for 5 months so cannot reasonably held accountable for recent performance. But at some point he must ....
wad collector
15/9/2015
07:36
What do you have to do to lose your job as ceo. The man running this company is incompetent yet keeps his job -very strange. Chairman and non-execs supine.
meijiman
08/9/2015
15:12
It's looking like this pattern and target will be confirmed today. No position.
bamboo2
08/9/2015
14:37
From Motley Fool today Oxford Instruments Oxford Instruments designs high-tech tools and systems for research and industry. Until recently, the company was a darling of investors — from the start of 2009 to the start of 2014 its shares soared from 150p to nearly 1,800p. However, there has been huge fall since, showing what can happen when a highly-rated growth company doesn’t live up to earnings-growth expectations. A statement ahead of the company’s AGM today saw the shares take another downward lurch — a 15% dive to 680p, as I write — with the Board announcing: “we have reduced our expectations for the full year”. The company cited “the sudden tightening of trade sanctions for sales to Russia, a slower-than-expected recovery in Japanese markets, and weaker trading in our Industrial Analysis business” as the primary factors. The group has been in the process of restructuring and lowering its cost base, and, while the Board believes the company is “well positioned to deliver its growth strategy over the medium term”, today’s news shows a continuing challenging environment. The once high P/E is now down into the low teens, but, with sentiment weak, the shares could fall further yet, and I would be looking for clear evidence of the company getting back on track before buying in. Of course, backing winners and avoiding losers are key to successful investing. But there are a number of other simple and straightforward steps that can help you on the road to stock-market riches and financial security.
wad collector
08/9/2015
09:02
Could start by changing the ceo IMHO.
meijiman
08/9/2015
08:45
Wonder if this is becoming a takeover target. Struggling at the moment.
tratante
08/9/2015
08:41
Needs eod close above approx 680 to avoid confirming H&S chart pattern.
bamboo2
08/9/2015
08:13
A difficult business to analyse ie compare with other companies -thus I'm not sure where your optimism came from? I think they overpaid for acquisitions which have not delivered. But its all smoke and mirrors really.
meijiman
08/9/2015
07:44
So much for my optimism , looks like a very slow 5%.
wad collector
18/8/2015
13:14
Added a few at 885. Just for trading ; I see a quick 5%.
wad collector
04/8/2015
08:46
An imminent return to above £10 looks likely to me , barring new bad news.
wad collector
24/7/2015
11:31
15 Jul 15 Investec Hold 906.50 1,100.00 950.00 Reiterates 09 Jul 15 Goldman Sachs Buy 906.50 900.00 900.00 Reiterates 02 Jul 15 Investec Hold 906.50 1,100.00 1,100.00 Reiterates 18 Jun 15 Barclays Capital Overweight 906.50 - 1,000.00 Retains 17 Jun 15 JP Morgan Cazenove Overweight 906.50 - - Reiterates 10 Jun 15 Liberum Capital Hold 906.50 - 930.00 Reiterates 10 Jun 15 Beaufort Securities Hold 906.50 - - Downgrades 10 Jun 15 JP Morgan Cazenove Overweight 906.50 1,200.00 1,200.00 Reiterates
wad collector
15/6/2015
17:30
"OXFORD INSTRUMENTS PLC - Director/PDMR Shareholding PR Newswire London, June 15 OXFORD INSTRUMENTS PLC Announcement to the London Stock Exchange On 15 June 2015 the Company’s Executive Directors were granted nil cost option awards over ordinary shares of 5 pence each under the Oxford Instruments plc Performance Share Plan (the "PSP") as noted below: Executive Director Number of shares under award Jonathan Flint 67,631 Kevin Boyd 45,087 Subject to the terms of the PSP, the awards will ordinarily vest and become exercisable as from the third anniversary of the grant of the awards subject to the grantee’s continued service and to the extent to which earnings per share growth and relative total shareholder return performance criteria are met over a measurement period comprising three financial years of the Company. Once exercisable, an award shall ordinarily remain exercisable until the eve of the tenth anniversary of the grant date of the awards. No consideration was paid for the grant of the awards and no consideration is due on the vesting and/or exercise of the awards. On the same date, Jonathan Flint’s wife and Company employee, Claire Flint, was granted options under the Oxford Instruments Executive Share Option Scheme over 20,350 ordinary shares of 5 pence at an option price of £10.28. The Company was notified of the above transactions on 15 June 2015." Does this mean the directors get this huge number of shares for nothing? What does it depend on?
bouleversee
12/6/2015
09:11
Sharp rise this morning - has the nadir passed?
wad collector
09/6/2015
11:01
Probably a good entry point. As you say not great figures -not disastrous either. If Andor going well some other bits must be slipping.
meijiman
09/6/2015
10:25
Results worse than market expected but I think an overreaction so bought back at 967p. 09 June 2015 Release Date: 7am Tuesday 9 June 2015 Oxford Instruments plc Announcement of Preliminary Results for the year to 31 March 2015 Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces its Preliminary Results for the year to 31 March 2015. Highlights: -- Orders grew by 13.0% to GBP386.6 million (2014: GBP342.2 million) -- Revenue grew by 7.1% to GBP385.5 million (2014: GBP360.1 million) -- On an Organic Constant Currency basis, Orders flat on prior year and Revenues declined by 5.4% -- Adjusted profit before tax* of GBP35.6 million (2014: GBP47.1 million), reflecting macro headwinds in Japan and Russia, and weaker trading than expected in Industrial Analysis -- Adjusted EPS* of 48.2p (2014: 67.7p) -- Andor Technology acquisition has integrated well and is performing strongly -- Cost reduction programme accelerated and delivering greater than planned savings -- Investment in future organic growth: R&D spend increased to GBP35.2 million (2014: GBP27.9 million) -- Proactive portfolio management to deliver long-term shareholder value: acquisition of MIR; joint venture to combine Oxford Instruments' Omicron business with Scienta Scientific AB -- Proposed final dividend of 9.30 pence (2014: 9.04 pence), giving a total dividend for the year of 13.0 pence (2014: 12.4 pence) *Adjusted numbers are stated to give a better understanding of the underlying business performance. Details of adjusting items can be found in Note 1. Jonathan Flint, Chief Executive of Oxford Instruments plc, said: "Overall, we have had a challenging year. We expect a return to organic growth in the coming year, with potential for margin improvement in the medium term. This reflects our swift and decisive action to improve our business, and our confidence that nanotechnology continues to drive long term demand for our high technology tools. Our strategy remains to grow our core markets of physical and materials science, and expand into life sciences." Enquiries:
wad collector
12/5/2015
13:58
I do like these spikey movements in the share price combined with a narrow spread of 0.3% , tempting to trade on them...sold a third at 1080.
wad collector
11/5/2015
11:26
From Beaufort Oxford Instruments (LON:OXIG) – Buy On Friday, Oxford Instruments announced the acquisition of Medical Imaging Resources (MIR), founded in 1990 and specializing in building, leasing and servicing of mobile medical imaging labs. The consideration comprises £6.8m on deal completion and a further £6.6m earn-out payable after one year. MIR has approximately £2.0m net debt at completion. MIR’s sales for the year 2014 stood at £10.8m and the pre-tax profit was £1.8m with gross assets worth £6.1m. MIR leases its mobile labs to the customers across the US and also services them. These labs are built in MIR’s factory, with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) systems from Siemens, GE, Philips and Toshiba. Our view: The acquisition of MIR bodes well for the future prospects of Oxford Instruments. The acquired business would be integrated into the company’s OIHealthcare division, thereby improving the company’s purchasing power and offering synergies in sections where there is duplication in operations. Both the companies serve General Electric MRI and CT machines in the US. Moreover, MRI has several other customers, for its mobile labs across the US that need to conduct CT and MRI trials but do not have additional infrastructure for the same. Oxford Instruments already enjoys a considerable brand equity and distribution network with an ever expanding network for its products. Thus, given its continued efforts to enhance operational efficiencies along with strategic acquisitions give the company a good upside potential. We retain a Buy rating for the stock.
wad collector
07/5/2015
18:06
Very weird.
small crow
Chat Pages: 32  31  30  29  28  27  26  25  24  23  22  21  Older
Your Recent History
LSE
OXIG
Oxford Ins..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191207 01:02:44